Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 4, 2022.
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
The NeurologyLive® has been covering news out of the Northeast Amyotrophic Lateral Sclerosis (NEALS) Consortium Annual Meeting all week, including the latest data and hottest topics, as well as interviews with experts in the care of ALS.
Mind Moments®, a podcast from NeurologyLive®, brings you exclusive interviews with a number of experts in the clinical care of multiple sclerosis, straight from the floor of the 2022 European Committee for Treatment and Research in Multiple Sclerosis Congress.
In the latest edition of our in-depth Q&A series, the adult neurologist at Allegheny Health Network provided perspective on why there has never been a better time to treat patients with myasthenia gravis.
In this NeurologyLive® Insights series, Paul Doghramji, MD, FAAFP, provides insight on the use of current treatment modalities for insomnia and the management of sleep disorders in primary care clinics.
Charlene Gamadelo, MD, provides an overview of insomnia and discusses the prevalence by race and gender, the variations in the presentation of symptoms in patients, and the pathways involved in sleep wakefulness cycles, among other topics, in this NeurologyLive® Insights series.